Cargando…

RNA binding protein-based risk score model for prognosis prediction of patients with hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Xu, Shengjun, Ding, Ning, Zheng, Sheng, Chen, Jun, Wan, Yafeng, Ling, Sunbin, Xu, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944357/ https://www.ncbi.nlm.nih.gov/pubmed/35940897 http://dx.doi.org/10.1097/CM9.0000000000002232

Ejemplares similares

Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma
por: Wang, Jingrui, et al.
Publicado: (2022)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

Ubiquitin‐specific protease 22 promotes tumorigenesis and progression by an FKBP12/mTORC1/autophagy positive feedback loop in hepatocellular carcinoma
por: Ye, Qianwei, et al.
Publicado: (2023)

The predictive value of the modified AFP model for liver transplantation outcomes in multinodular hepatocellular carcinoma patients
por: Wang, Jingrui, et al.
Publicado: (2023)

Association Between Olfactomedin 4 and Postoperative Prognosis in Patients With Early-Stage Hepatocellular Carcinoma
por: Chen, Wan-Yuan, et al.
Publicado: (2020)

Comment on ‘Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?’
por: Liu, Yuying, et al.
Publicado: (2018)

Proliferating cell nuclear antigen (PCNA) overexpression in hepatocellular carcinoma predicts poor prognosis as determined by bioinformatic analysis
por: Li, Dan-Dan, et al.
Publicado: (2021)

Single-cell sequencing and bulk RNA sequencing reveal a cell differentiation-related multigene panel to predict the prognosis and immunotherapy response of hepatocellular carcinoma
por: Liu, Jifeng, et al.
Publicado: (2023)

Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy
por: Xu, Shengjun, et al.
Publicado: (2021)

Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma
por: Wen, Xue, et al.
Publicado: (2019)

Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China (2021 edition)
por: Chen, Jun, et al.
Publicado: (2022)

Response to immunotherapy plus anti‐angiogenic agent combination challenges hepatocellular carcinoma prognostic scores
por: Adhoute, Xavier, et al.
Publicado: (2022)

Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”
por: Sohn, Won, et al.
Publicado: (2023)

Clinical Features and Clonal Origin of Diffuse Hepatocellular Carcinoma
por: Wang, Zheng-Lu, et al.
Publicado: (2018)

Porphyria and hepatocellular carcinoma
por: Pierach, C.A.
Publicado: (1987)

Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment
por: Zhang, Fa-Peng, et al.
Publicado: (2020)

A novel machine learning derived RNA-binding protein gene–based score system predicts prognosis of hepatocellular carcinoma patients
por: Zhang, Qiangnu, et al.
Publicado: (2021)

Integrated bioinformatic analysis of RNA binding proteins in hepatocellular carcinoma
por: Wang, Ling, et al.
Publicado: (2020)

Dermoscopy of cutaneous metastases from primary hepatocellular carcinoma
por: Liu, Xiao-Yang, et al.
Publicado: (2019)

Systematic Construction and Validation of an RNA-Binding Protein-Associated Model for Prognosis Prediction in Hepatocellular Carcinoma
por: Tian, Siyuan, et al.
Publicado: (2021)

LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients
por: Ma, Yang, et al.
Publicado: (2023)

High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma
por: Liao, Weijia, et al.
Publicado: (2014)

Glutamine Metabolism Scoring Predicts Prognosis and Therapeutic Resistance in Hepatocellular Carcinoma
por: Ying, Leqian, et al.
Publicado: (2021)

The development of a cSMART-based integrated model for hepatocellular carcinoma diagnosis
por: Wu, Tong, et al.
Publicado: (2023)

PDZ Binding Kinase/T-LAK Cell-Derived Protein Kinase Plays an Oncogenic Role and Promotes Immune Escape in Human Tumors
por: Feng, Tingting, et al.
Publicado: (2021)

Cholesterol and hepatocellular carcinoma risk: reliable and actionable?
por: Braillon, Alain
Publicado: (2021)

Hepatocellular Carcinoma Prevention by Aspirin: Are Platelets the Link?
por: Nischalke, Hans Dieter, et al.
Publicado: (2021)

Overexpression of long noncoding RNA LINC00882 is associated with poor prognosis in hepatocellular carcinoma
por: Zhu, Lei, et al.
Publicado: (2018)

A commentary on ‘Laparoscopic versus open repeat hepatectomy for recurrent hepatocellular carcinoma: a systematic review and meta-analysis of propensity score-matched cohort studies’
por: Zhong, Furui, et al.
Publicado: (2023)

Clinical characteristics, treatments, and prognosis of patients with multiple primary carcinoma of head and neck
por: Liu, Kun, et al.
Publicado: (2020)

Perfect prognosis of a boy with alveolar rhabdomyosarcoma of the nasal wing treated with brachytherapy and chemotherapy
por: Hu, Hui-Min, et al.
Publicado: (2021)

Elevated Aspartate Aminotransferase to Alanine Aminotransferase Ratio Predicts Poor Outcome in Hepatocellular Carcinoma
por: von Felden, Johann, et al.
Publicado: (2020)

GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma
por: Zhang, Sheng, et al.
Publicado: (2017)

Proximity editing to identify RNAs in phase-separated RNA binding protein condensates
por: Zhou, Guilong, et al.
Publicado: (2021)

The effect of SNPs in lncRNA as ceRNA on the risk and prognosis of hepatocellular carcinoma
por: Mo, Han, et al.
Publicado: (2022)

An lncRNA Model for Predicting the Prognosis of Hepatocellular Carcinoma Patients and ceRNA Mechanism
por: Zhang, Hao, et al.
Publicado: (2021)

Long non-coding RNA-based risk scoring system predicts prognosis of alcohol-related hepatocellular carcinoma
por: Luo, Yue, et al.
Publicado: (2020)

A commentary on ‘Significance of anatomical resection and resection margin status in patients with HBV-related hepatocellular carcinoma and microvascular invasion: a multicenter propensity score-matched study’
por: Yang, Shiye, et al.
Publicado: (2023)

Reply to ‘Comment on ‘Circulating Neutrophils in patients with hepatocellular carcinoma”
por: Chan, Stephen L., et al.
Publicado: (2018)

EGFR blockade confers sensitivity to cabozantinib in hepatocellular carcinoma
por: Ma, Xuhui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r4r8drcujq6kopoh3vr358ounb